Genpharmasec informs about outcome of board meeting

11 Dec 2023 Evaluate

Pursuant to the provisions of Regulation 30 (2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Genpharmasec has informed that the Board of Directors of the Company in their meeting held on Wednesday, 08th November, 2023 has: Considered and approved and taken on records the Un-audited Financial Results along with Limited Review Report for the quarter and half year ended 30th September, 2023 prepared in terms of IND-AS, pursuant to Regulation 33 of (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Considered and approved and taken on records the Un-audited Statement of Assets and Liabilities for the quarter and half year ended 30th September, 2023. The Board Meeting commenced at 04.00 pm (IST) and concluded at 4:37 pm (IST).

The above information is a part of company’s filings submitted to BSE.


Genpharmasec Share Price

1.17 0.01 (0.86%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 271.70
Adani Enterprises 2019.40
Amrapali Industries 13.19
Rashi Peripheral 358.60
PDS 338.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×